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Abstract
Background. Polygenic risk scores (PRS) for depression correlate with depression status and
chronicity, and provide causal anchors to identify depressive mechanisms. Neuroticism is
phenotypically and genetically positively associated with depression, whereas psychological
resilience demonstrates negative phenotypic associations. Whether increased neuroticism
and reduced resilience are downstream mediators of genetic risk for depression, and whether
they contribute independently to risk remains unknown.
Methods. Moderating and mediating relationships between depression PRS, neuroticism,
resilience and both clinical and self-reported depression were examined in a large, popula-
tion-based cohort, Generation Scotland: Scottish Family Health Study (N = 4166), using linear
regression and structural equation modelling. Neuroticism and resilience were measured by
the Eysenck Personality Scale Short Form Revised and the Brief Resilience Scale, respectively.
Results. PRS for depression was associated with increased likelihood of self-reported and clin-
ical depression. No interaction was found between PRS and neuroticism, or between PRS and
resilience. Neuroticism was associated with increased likelihood of self-reported and clinical
depression, whereas resilience was associated with reduced risk. Structural equation modelling
suggested the association between PRS and self-reported and clinical depression was mediated
by neuroticism (43–57%), while resilience mediated the association in the opposite direction
(37–40%). For both self-reported and clinical diagnoses, the genetic risk for depression was
independently mediated by neuroticism and resilience.
Conclusions. Findings suggest polygenic risk for depression increases vulnerability for self-
reported and clinical depression through independent effects on increased neuroticism and
reduced psychological resilience. In addition, two partially independent mechanisms –
neuroticism and resilience – may form part of the pathway of vulnerability to depression.
Introduction
Major depressive disorder (MDD) is a pervasive and disabling psychiatric condition charac-
terised by periods of low mood and anhedonia, with an estimated lifetime prevalence of
16% (Levine et al. 2014). MDD has substantial public health implications, with research sug-
gesting the disorder increases mortality risk and exacerbates cognitive decline (Reddy, 2010;
Ferrari et al. 2013). Depression is substantially heritable (Sullivan et al. 2000) and has a com-
plex genetic architecture (Liu et al. 2011; Schulze et al. 2014). Whilst modest progress has been
made to understand the heterogeneity of genetic risk factors for MDD (Caspi et al. 2003;
Duncan & Keller, 2011; Wray et al. 2012), genome-wide association studies have indicated
that MDD risk is influenced by a large number of common allelic variations of small effect
rather than specific susceptibility loci (Lubke et al. 2012).
A now-commonplace method applied to examine these genetic influences is polygenic risk
scores (PRS) (Demirkan et al. 2011) which are used as a measure of ‘genetic liability’ asso-
ciated with a particular phenotype (Wray et al. 2008). PRS are founded on the assumption
that whereas genetic variants with very small individual effects may not meet genome-wide
significance thresholds (depending on statistical power), their cumulative associations may
have a much stronger effect (Wray et al. 2007, 2008). Polygenic vulnerabilities have been
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identified in several psychiatric disorders (Purcell et al. 2009;
Ripke et al. 2013). Specifically to MDD, PRS have been found
to correlate with both the status and chronicity of the disorder
(Sullivan & MDD Working Group of the Psychiatric Genomics
Consortium, 2012; Levine et al. 2014). However, to date, PRS typ-
ically account for only 1–2% of variance in MDD (Demirkan et al.
2011; Cross-Disorder Group of the Psychiatric Genomics
Consortium, 2013; Ripke et al. 2013) suggesting other factors
are also influencing risk for the disorder.
Personality is frequently linked with vulnerability to psychi-
atric illness (Fanous & Kendler, 2004), with one of the strongest
associations being between MDD and neuroticism (Kotov et al.
2010). Neuroticism is a partly-heritable personality trait charac-
terised by emotional instability, negative emotional response,
and stress sensitivity (Lahey, 2009). Phenotypically, neuroticism
is strongly positively associated with MDD both cross-sectionally
(Chan et al. 2007; Roelofs et al. 2008; Navrady et al. 2017a) and
prospectively (Kendler et al. 2006; Farmer et al. 2008). There is
also evidence that neuroticism and depression are strongly genet-
ically correlated (Jardine et al. 1984; Kendler et al. 1993). For
example, evidence from twin studies indicates that neuroticism
and MDD share up to two-thirds of their genetic variance
(Carey & DiLalla, 1994; Fanous et al. 2002; Hettema et al.
2006). Furthermore, de Moor and colleagues (de Moor et al.
2015) found that neuroticism and MDD can be equally well
explained by neuroticism PRS (up to 1.05% variance explained),
in addition to being able to predict MDD based on neuroticism
PRS alone. As neuroticism is a relatively stable trait (Lahey,
2009), it is hypothesised that it may act as an indirect measure
of later risk for MDD, and as such is an important phenotype
for MDD genetic studies.
Whereas research into MDD risk has dominated the field,
interest in psychological resilience has grown substantially over
recent decades (Luthar et al. 2006; Russo et al. 2012; Southwick
& Charney, 2012). Resilience is often described as the positive
pole of individual differences in people’s susceptibility to MDD,
as it is widely observed that not all individuals at risk for the dis-
order become unwell (Collishaw et al. 2007; Alim et al. 2008).
Resilience has been related to increased positive and reduced
negative affect (Smith et al. 2010), which suggests potentially dif-
ferent mechanisms for vulnerability and protection (Fredrickson,
2001). Cross-sectionally, it was found that individuals scoring
higher on self-reported resilience (using The Connor–Davidson
Resilience Scale questionnaire) reported fewer psychiatric symp-
toms following childhood emotional neglect than did those with
lower levels of resilience (Campbell-Sills et al. 2006). Using the
same measure, higher resilience has been found to mitigate the
severity of depressive symptoms in individuals exposed to trauma
(Wingo et al. 2013). Furthermore, reports suggest that resilience
reduces risk for depression in individuals with high genetic load-
ing for the disorder (Wichers et al. 2007; Wichers et al. 2008;
Geschwind et al. 2010).
Current research suggests a positive association between neur-
oticism and MDD; self-reported resilience and depression show a
negative association. However, studies often fail to adequately
consider how MDD is measured (Adli et al. 2006; Cameron
et al. 2011). Whilst moderate associations between clinical and
self-reported measures of MDD suggest the two approaches are
interchangeable (Kessler et al. 1998; Rush et al. 2006), important
distinctions between clinical and self-reported depression have
been found. Specifically, self-reported and clinical measures of
depression have each been found to provide unique information
about the disorder not captured by the other (Uher et al. 2012)
that may help to elucidate underlying mechanisms (Fava et al.
1986; Möller, 2000).
Here, we report a moderation and a mediation analysis of a
large population-based cohort (Generation Scotland: Scottish
Family Health Study) who completed both self-reported and clin-
ical measures of MDD. First, in a series of moderation analyses,
we investigated whether the association between PRS for MDD
and clinical and self-reported depression (Sullivan & MDD
Working Group of the Psychiatric Genomics Consortium, 2012;
Levine et al. 2014) was moderated by neuroticism or resilience.
We predicted that neuroticism would be associated with increased
likelihood of both clinical and self-reported depression, whilst
resilience would associate in the opposite direction, in line with
previous findings. Second, using structural equation modelling,
we examined if neuroticism mediates the relationship between
PRS for MDD and both clinical and self-reported MDD to
increase the risk for the disorder, and if resilience would mediate
in the opposite direction. The path models we tested are illu-
strated in Fig. 1.
Methods
Participants
Participants were sampled from the Generation Scotland: Scottish
Family Health Study (GS:SFHS) – a family-based epidemiological
cohort recruited between 2006 and 2011 (Smith et al. 2006, 2013).
At baseline, participants provided extensive data, including per-
sonality measures, a structured interview for clinical MDD diag-
nosis and DNA extraction. In 2014, GS:SFHS participants were
re-contacted and asked to take part in a follow-up assessment
of mental health and resilience (Navrady et al. 2017b), providing
a range of questionnaire measures including resilience and self-
reported MDD. Full details of the initial recruitment and
follow-up have been given elsewhere (Smith et al. 2006; 2013;
Navrady et al. 2017b) and in the online Supplementary
Materials. This study includes 4166 unrelated individuals
(Meanage = 56.01, S.D. = 12.31, Nfemale = 2634) with complete data
of interest.
GS:SFHS received ethical approval from the NHS Tayside
Committee (reference 05/S1401/89 and 14/SS/0039). All partici-
pants provided written informed consent.
Study assessments
DNA was extracted from participants for whole-genome genotyp-
ing, the procedures for which have been reported extensively else-
where (Smith et al. 2006; Zeng et al. 2016). Genome-wide
genotype data were available for all participants in the current
study from which PRS were created. Using the genotype data
and PRCise software (Euesden et al. 2015), PRS were calculated
by computing the genome-wide sum of trait-associated alleles
across genetic loci, weighted by their effect in an independent
genome-wide association study (GWAS). The GWAS summary
statistics used for these PRS were those from the large unpub-
lished meta-analysis of MDD from the Psychiatric Genetics
Consortium (PGC MDD29; 130 664 MDD cases v. 330 470 con-
trols), although GS:SFHS participants were removed from these
summary statistics before calculating PRS. Here, we only report
findings using a PRS threshold of 0.50 as preliminary analysis
indicated this threshold was most predictive of both self-reported
2 L. B. Navrady et al.
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and clinical MDD in this sample (see online Supplementary
Material).
Neuroticism was assessed using the self-report questionnaire
Eysenck Personality Questionnaire Short Form-Revised (EPQ-SF;
Eysenck, 1991). The neuroticism subsection of the EPQ-SF consists
of 12 ‘Yes/No’ questions (e.g. ‘Are you a worrier?’). Scores range
from 0 to 12, with higher scores indicative of higher levels of neur-
oticism. This scale has been concurrently validated with other
quantitative measures of neuroticism (Gow et al. 2005) with high
reliability (Eysenck et al. 1985).
Psychological resilience was assessed using the Brief Resilience
Scale (BRS; Smith et al. 2008), a self-report questionnaire used to
assess an individual’s ability to ‘bounce back’ or recover from stress.
The BRS consists of six statements (e.g. ‘I usually come through
difficult times with little trouble’) answered on a five-point scale
from ‘Strongly Disagree’ to ‘Strongly Agree’. After reverse coding
of even-numbered questions, a total resilience score was calculated
by computing the mean of six questions. The BRS has been found
to have a one-factor structure, demonstrating good internal
consistency and test–retest reliability (Smith et al. 2008).
Participants were screened for a clinical diagnosis of MDD at
baseline using the Structured Clinical Interview for DSM-IV Axis
I Disorders (SCID; First et al. 1997). Diagnosis of MDD followed
DSM-IV criteria (American Psychiatric Association, 2003); if
either symptom of depressive mood or anhedonia are endorsed,
a minimum of four further symptoms must also be endorsed.
These symptoms must have lasted nearly all day, every day for a
minimum of 2 weeks. Interview procedures and quality control
protocol have been described elsewhere (Fernandez-Pujals et al.
2015). As the interviews were conducted by a trained researcher
SCID MDD status can be used as a proxy for clinical MDD. In
this sample, 664 individuals met criteria for clinical MDD
(16%), and 3502 were non-MDD cases (84%).
During re-contact, self-reported MDD was assessed using a
questionnaire developed by the World Health Organization: the
Composite International Diagnostic Interview – Short Form
(CIDI-SF; Kessler et al. 1998). The CIDI-SF evaluates self-
reported MDD according to DSM-IV (American Psychiatric
Association, 2003) criteria and employs a stem-branch logic to
eliminate individuals who fail to endorse a minimum of four
symptoms (in addition to depressed mood and/or anhedonia)
with clinical significance. Although the CIDI-SF is a self-report
measure of MDD, respondents meeting MDD criteria with the
CIDI-SF have been shown to reliably meet full diagnostic criteria
with excellent accuracy if given the full version of the question-
naire (Kessler et al. 1998). A total of 1068 individuals in the men-
tal health follow-up sample met criteria for self-reported MDD
(26%), with 3098 classified as non-MDD cases (74%).
Analyses
All analyses were conducted using R version 3.2.3 (http://www.
R-project.org).
Moderation
We performed generalised linear models to examine the moderat-
ing associations of both neuroticism and resilience on the rela-
tionship between PRS for MDD and clinical and self-reported
MDD (SCID and CIDI-SF, respectively). As MDD status is a
dichotomous variable, we specified a ‘binary’ family with a logit
link function in the analysis. Three moderation models were com-
puted for each MDD category (self-reported and clinical). A basic,
first-step model was estimated to examine the validity of the PRS
by testing for an association between genetic risk for depression
and both clinical and self-reported MDD status. In the second
step of the analysis, an interaction model was fitted to estimate
the moderating association of neuroticism (total EPQ-SF score)
on the contribution of genetic liability to both clinical and self-
reported MDD. Another model was then fitted to examine the
interaction between PRS and resilience (total BRS score) on sus-
ceptibility to clinical and self-reported MDD. Regression coeffi-
cients are reported as odds ratios (ORs) with 95% confidence
intervals (CIs). The p values presented are raw and uncorrected
for multiple testing. All continuous variables have been scaled
to have a mean of 0 and a standard deviation of 1. As neuroticism
and resilience were measured at different time-points, neuroticism
was controlled for age at baseline (Aget1) and resilience was
controlled for age at re-contact (Aget2) prior to them entering
the moderation models. All models were controlled for four
ancestry-informative principal components to take account of
possible population stratification; results of these associations
are presented in the online Supplementary Material.
Mediation
The structural equation modelling package ‘lavaan’ (Rosseel,
2012) was used in R to estimate and compare models of the
types shown in Fig. 1. Diagonally Weighted Least Squares
(DWLS) estimation was used in all models to account for MDD
Fig. 1. The theoretical mediation models tested in the present study. A first set of models predict clinical MDD status from polygenic risk (PRS) for the disorder (e.g.
Model 1A), a second set of models will model self-reported MDD as an outcome (e.g. Model 2A). These models will be conducted with both SCID MDD status repre-
senting clinical MDD and CIDI-SF MDD status representing self-reported MDD. ‘A’ models propose that the association between PRS for MDD and clinical and self-
reported MDD may be mediated by the latent factor neuroticism. ‘B’models propose that the association between PRS for depression and clinical and self-reported
MDD may be mediated by the latent factor resilience. ‘C’ models propose that, in addition to neuroticism mediating PRS to increase risk for clinical and self-
reported MDD, resilience may provide a separate mediating effect to reduce the risk for clinical and self-reported MDD in those genetically liable for the dis-
order(s). By contrast, ‘D’ models test the assumption that neuroticism and resilience may mediate the link between PRS and clinical and self-reported MDD as
one underlying factor; Neuroticism + Resilience. MDD, Major Depressive Disorder; PRS, Polygenic Risk Score; SCID, Structured Clinical Interview for DSM-IV Axis I
Disorders; CIDI-SF, Composite International Diagnostic Interview – Short Form.
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being a binary variable. The variance of each latent construct was
fixed to 1 so as to identify each model. To assess the absolute fit of
each model, a range of model-fit indices are reported (MacCallum
et al. 1996; McQuitty): Root mean square error of approximation
(RMSEA; values indicating good fit <0.05), comparative fit index
(CFI; values >0.95), and Tucker–Lewis index (TLI; values >0.95).
To calculate the percentage mediation in each model we divided
the sum of the indirect paths by the total variance explained by
the model (Rosseel, 2012). For comparison of one- and two-factor
models, we performed chi-squared tests, as an Akaike information
criterion (AIC) cannot be computed when using the DWLS
method.
As seen in Fig. 1, four mediation models have been produced
each for SCID and CIDI-SF MDD status to examine the associ-
ation between PRS and clinical and self-reported MDD, respect-
ively. ‘A’ models examined the mediating effects of neuroticism
(estimated as a latent variable using individual EPQ-SF items)
on the relationship between PRS and MDD. The second set of
models (‘B’) investigated resilience as a latent variable indicated
by individual BRS items as a mediator between PRS and MDD.
‘C’ models examined neuroticism and resilience as two separate
latent mediating variables between PRS and MDD. We also exam-
ined the phenotypic correlation between these latent variables
within the model. Finally, we created a latent variable, named
‘Neuroticism + Resilience’, consisting of all individual EPQ-SF
and BRS questionnaire items to determine if one general factor
can better explain the relationship between PRS and clinical
and self-reported MDD (‘D’ models).
Results
Descriptive statistics and a correlation matrix are provided in
Table 1. As illustrated in Table 1, resilience and neuroticism were
moderately negatively correlated (r =−0.48, p < 0.001). Further
demographic information, a full correlation matrix, and the differ-
ences and overlap between clinical and self-reported MDDmeasures
in this study are outlined in the online Supplementary Material.
Moderation
Validity of the MDD PRS
The polygenic risk for MDD was found to be associated with
increased likelihood of clinical MDD (see Table 2). A 1 S.D.
increase in genetic liability to depression was associated with an
increased likelihood of clinical depression by an OR of 1.20
[(95% CIs 1.11–1.31), p < 0.001]. Age was found to be associated
with clinical MDD, and being female increased clinical MDD like-
lihood by an OR of 1.72 (95% CIs 1.42–2.07, p < 0.001).
Similar results were obtained for self-reported MDD, see
Table 2. Specifically, a 1 S.D. increase in polygenic risk for depres-
sion increased likelihood of self-reported depression by an OR of
1.18 (95% CIs 1.10–1.27), p < 0.001). Age had a small negative
association with self-reported MDD, whereas being female
increased self-reporting of depression by an OR of 1.94 (95%
CIs 1.66–2.28), p < 0.001).
Interaction between neuroticism and PRS on MDD
No interaction was found between neuroticism and PRS on clin-
ical MDD status [OR 0.92, (95% CI 0.84–1.00), p = 0.062], see
Table 2. PRS remained associated with clinical MDD [OR 1.16,
(95% CIs 1.05–1.29), p = 0.004], and neuroticism independently
associated with increased likelihood of clinical MDD status [OR
2.49, (95% CI 2.28–2.72), p < 0.001].
No interaction was found between neuroticism and PRS on
self-reported MDD [OR 0.97, (95% CI 0.90–1.04), p = 0.416],
see Table 2. PRS remained associated with self-reported depression
when co-varying for neuroticism (OR 1.13, (95% CIs 1.05–1.22),
p = 0.002], and neuroticism also remained strongly independently
associated with self-reported MDD status (OR 1.81, (95% CI
1.68–1.95), p < 0.001].
Interaction between resilience and PRS on MDD
No interaction was found between PRS and resilience in association
with clinical MDD [OR 1.04, (95% CI 0.95–1.14), p = 0.373]; see
Table 2. The main effect of PRS was associated with clinical
MDD [OR 1.19, (95% CI 1.08–1.32), p = 0.001]. A strong inverse
relationship was found between resilience and clinical depression
[OR 0.44, (95% CI 0.40, 0.48), p < 0.001].
No interaction was found between PRS and resilience on self-
reported MDD [OR 1.06, (95% CI 0.97–1.16), p = 0.211; see
Table 2]. Whereas the main effect of PRS was associated with
increased likelihood of self-reported depression [OR 1.17, (95%
CI 1.06–1.30), p = 0.002], resilience was found to be associated
with a reduction in self-reported MDD [OR 0.44, (95% CI
0.40–0.48), p < 0.001].
Mediation
Mediation of neuroticism
Model 1A showed no direct association between PRS and clinical
MDD status (β = 0.04, p = 0.077), although this pathway was esti-
mated to explain 4.4% of the variance. The path from PRS to
neuroticism demonstrated a small positive association (β = 0.07,
p < 0.001). A larger association between neuroticism and clinical
MDD was found (β = 0.87, p < 0.001). This indirect pathway
explained 5.8% of the variance. As shown in Table 3, Model 1A
had a good fit to the data, and suggested that 57% of the associ-
ation of genetic liability for depression on clinical MDD was
mediated by neuroticism.
In Model 2A, the direct path between PRS and self-reported
MDD (β = 0.06, p = 0.013), was estimated to explain 5.5% of the
variance. A small association between PRS and neuroticism was
found (β = 0.06, p < 0.001), whilst the path from neuroticism to
self-reported MDD showed a much stronger association (β =
0.65, p < 0.001). Together, this indirect pathway explained 4.2%
of the variance. As shown in Table 3, Model 2A had a good fit
to the data. This model suggested that 43% of the association of
genetic liability for depression with self-reported MDD was
mediated by neuroticism.
Mediation of resilience
In Model 1B, a direct association between PRS and clinical MDD
was found (β = 0.06, p = 0.008, explaining 6.4% of the variance).
However, a small negative association between PRS and resilience
(β =−0.07, p < 0.001), and a larger negative association from
resilience to clinical MDD (β =−0.58, p < 0.001), explained 3.8%
of the variance. Model 1B’s fit to the data was also good (see
Table 3), and suggested that 37% of the association between
PRS and clinical MDD was mediated by resilience.
A direct association between PRS and self-reported MDD was
found in Model 2B (β = 0.06, p = 0.008), which was estimated to
explain 5.8% of the variance. A small, negative association
between PRS and resilience was found (β = −0.07, p < 0.001), in
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addition to a larger negative association between resilience and
self-reported MDD (β =−0.60, p < 0.001), which together
explained 3.9% of the variance. Model 2B’s fit to the data was
also good (see Table 3), and suggested that 40% of the association
between PRS and self-reported MDD was mediated by resilience.
Two-factor mediation
As shown in Fig. 2, Model 1C found no association between PRS
and clinical MDD was found (β = 0.04, p = 0.108), although this
direct path was estimated to explain 3.9% of the variance.
Whilst a small positive association was found between PRS and
neuroticism (β = 0.06, p < 0.001), a small inverse relationship
was found between PRS and resilience (β =−0.07, p < 0.001).
A positive association was found between neuroticism and clinical
MDD (β = 0.68, p < 0.001), whereas a negative association was
found between resilience and clinical depression (β = −0.30, p <
0.001). Neuroticism and resilience were moderately negatively
correlated (r =−0.25). Table 3 indicates that Model 1C had a
good fit to the data. Approximately 61% of the association
between PRS and clinical MDD was found to be mediated by
neuroticism and resilience, as two separate factors.
In Model 2C, we examined the mediating associations of both
neuroticism and resilience as separate constructs between PRS
and self-reported MDD, within the same model. As shown in
Fig. 2, the direct association between PRS and CIDI-SF
(β = 0.05, p = 0.033), was estimated to explain 4.7% of the vari-
ance. A small positive association was found between PRS and
neuroticism (β = 0.06, p < 0.001), and an inverse relationship
found between PRS and resilience (β =−0.07, p < 0.001). The
same direction of association was evident in the path between neur-
oticism and self-reported MDD (β = 0.30, p < 0.001) and between
resilience and self-reported depression (β =−0.47, p < 0.001).
Neuroticism and resilience were found to be negatively correlated
(r =−0.25). As shown in Table 3, Model 2C had a good fit to
the data, with neuroticism and resilience as two separate factors
explaining approximately 52% of the association between PRS
and self-reported MDD.
Neuroticism and resilience as one underlying factor
Model 1D examined if neuroticism and resilience reflect opposite
ends of the same trait by creating a latent variable (Neuroticism +
Resilience) comprising of all the individual item responses from
both the EPQ-SF and the BRS. A small association between
PRS and clinical MDD was found (β = 0.06, p = 0.023), explaining
6% of the variance. An association between PRS to Neuroticism +
Resilience was found (β = 0.04, p < 0.001) in addition to a positive
association between Neuroticism + Resilience and clinical MDD
(β = 1.19, p < 0.001). In total, Model 1D explained 47% of the
mediation between PRS and clinical MDD. As shown in
Table 3, Model 1C appears to fit the data much better than does
Model 1D χ2(8) = 300.48, p < 0.001, suggesting that neuroticism
and resilience reflected two partially separate constructs independ-
ently mediating the relationship between PRS for MDD and clinical
depression.
Model 2D also investigated whether one underlying factor can
better explain the mediation of the PRS-depression relation by
neuroticism and resilience. A small association was found
between PRS and self-reported MDD (β = 0.05, p = 0.025) which
was estimated to explain 4.9% of the variance. A small association
between PRS and Neuroticism + Resilience was found (β = 0.04,
p < 0.001) in addition to a positive association between
Neuroticism + Resilience and self-reported MDD (β = 1.21,
p < 0.001). Together, these indirect paths explained 4.8% of the
variance, whilst the model itself explained 49% of the mediation
between PRS and self-reported MDD. Model 2D’s fit to the
data was significantly poorer than that of Model 2C (see
Table 3), χ2(8) = 260.37, p < 0.001. This suggests neuroticism
and resilience should be considered partially independent con-
structs associated with different mediating mechanisms in the
association between genetic liability for MDD and self-reported
depression.
Discussion
Here, we report the first study investigating the moderating and
mediating associations of neuroticism and resilience on genetic
liability for MDD on both clinical and self-reported depression
in a large cohort of individuals. Our results suggest that polygenic
risk for MDD is associated with an increased likelihood of both
clinical and self-reported depression, replicating previous findings
(Sullivan & MDD Working Group of the Psychiatric Genomics
Consortium, 2012; Levine et al. 2014). Consistent with existing lit-
erature (Farmer et al. 2008; Roelofs et al. 2008; Navrady et al.
2017a), neuroticism is associated with increased likelihood of
Table 1. Correlation Matrix and Descriptive Statistics for baseline age, age at recontact, sex, resilience, neuroticism, clinical and self-reported MDD status
Aget1 Aget2 Sex Resilience Neuroticism SCID CIDI-SF Mean (S.D.) N (%)
Aget1 – 50.28 (12.34)
Aget2 0.99 – 56.01 (12.31)
Sex (F) −0.09** −0.09** – 2634 (63)
Resilience 0.05 0.05 −0.10** – 3.52 (0.82)
Neuroticism −0.14 −0.14 0.17** −0.48 – 3.70 (3.17)
SCID −0.04** −0.04** 0.18* −0.31** 0.36** – 664 (16)
CIDI-SF −0.08** −0.08** 0.24* −0.35** 0.29** 0.60* – 1068 (26)
Aget1, Age at baseline; Aget2, Age at re-contact; Resilience, Total score from the Brief Resilience Scale; Neuroticism, Total score from the Eysenck Personality Questionnaire Short-Form; SCID,
Structured Clinical Interview for DSM-IV Axis I Disorders representing clinical MDD; CIDI-SF, Composite International Diagnostic Interview – Short Form representing self-reported MDD.
N.B. All p values significant at p⩽ 0.01.
Demographic information for Sex represents the number and percentage of females in this sample. Demographic details for SCID and CIDI-SF represent the number and percentage of
participants meeting criteria for clinical and self-reported MDD, respectively.
All coefficients represent Pearson correlations except those denoted by * which represents tetrachoric correlations – resultant from both variables being binary, and those denoted by **
which represent point biserial correlations – resultant from binary and continuous variables.
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both clinical and self-reported MDD, whereas resilience was
found to associate in the opposite direction (Geschwind et al.
2010; Wingo et al. 2013). Overall, our moderation analyses
demonstrate an association whereby both genetic liability for
MDD and neuroticism increases the likelihood of both clinical
and self-reported depression, independently, whereas resilience
associates with the reduced likelihood for both clinical and
self-reported depression, even after adjusting for genetic vulner-
ability. However, neuroticism and resilience did not show a multi-
plicative relation with the PRS, boosting and reducing the size of
its association with depression, respectively. Structural equation
modelling of this data suggests that genetic liability for MDD is
largely mediated by neuroticism to increase the risk for clinical
and self-reported depression, whilst resilience mediates PRS to
mitigate risk for both clinical and self-reported MDD. Results
from this study demonstrate that neuroticism and resilience inde-
pendently mediate the effects of genetic risk on depression, for
both self-reported and clinical measures of MDD.
Whereas the results from our moderation analyses results are
consistent with those previously found for PRS (Levine et al.
2014), neuroticism (de Moor et al. 2015) and resilience (Geschwind
et al. 2010), our meditational analyses reported novel findings.
Consistent with the possibility that polygenic genetic differences
shape susceptibility to MDD, our findings further suggest that
this relationship is driven by two partially separate mediating
mechanisms; one in which neuroticism increases the risk for
both clinical and self-reported MDD, the other in which resilience
reduces the same risk. Evidence for neuroticism and resilience
being partially independent mechanisms comes from our finding
that the two measures are not perfectly correlated (r =−0.48), in
addition to our structural equation models which demonstrate
two separate associations.
It is possible that the meditational associations of neuroticism
and resilience can be explained by the role of positive and negative
emotions. It is well documented that neuroticism is characterised
by a range of negative emotions highly associated with MDD
Table 2. Results of a generalised linear model predicting odds ratios for self-reported and clinical MDD status, p value, upper and lower 95% confidence intervals
and the Akaike Information Criterion




95% CIs p Value AIC
SCID Aget1 0.99 0.99 1.00 0.031 3607.60
Sex (F) 1.71 1.42 2.07 <0.001
PRS 1.20 1.11 1.31 <0.001
CIDI-SF Aget2 0.99 0.98 0.99 <0.001 4632.80
Sex (F) 1.94 1.66 2.28 <0.001
PRS 1.18 1.10 1.27 <0.001
SCID Age t1 0.99 0.99 1.00 0.026 3155.90
Sex (F) 1.33 1.09 1.63 0.005
PRS 1.16 1.05 1.29 0.004
Neuroticism 2.49 2.28 2.72 <0.001
PRS × Neuroticism 0.92 0.84 1.00 0.062
CIDI-SF Aget2 0.99 0.98 0.99 <0.001 4366.40
Sex (F) 1.66 1.41 1.95 <0.001
PRS 1.13 1.05 1.22 0.002
Neuroticism 1.81 1.68 1.95 <0.001
PRS × Neuroticism 0.97 0.90 1.04 0.416
SCID Aget1 0.99 0.99 1.00 0.030 3251.90
Sex (F) 1.53 1.26 1.86 <0.001
PRS 1.17 1.06 1.30 0.002
Resilience 0.44 0.40 0.48 <0.001
PRS × Resilience 1.06 0.97 1.16 0.211
CIDI-SF Aget2 0.99 0.98 0.99 <0.001 4156.80
Sex (F) 1.80 1.52 2.12 <0.001
PRS 1.14 1.06 1.24 0.001
Resilience 0.43 0.40 0.47 <0.001
PRS × Resilience 1.07 0.99 1.17 0.080
SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, representing clinical MDD; CIDI-SF, Composite International Diagnostic Interview – Short Form, representing self-reported MDD;
MDD, Major Depressive Disorder; AIC, Akaike Information Criterion; PRS, Polygenic Risk Score; Aget1, Age at the time of baseline; Aget2, Age at the time of re-contact.
N.B. Neuroticism has been controlled for Aget1 and resilience has been controlled for Aget2 before entering the model. Four principal components controlling for population stratification
have been adjusted for and are reported in the online Supplementary Material.
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(Chan et al. 2007; Navrady et al. 2017a). Although resilience has
received less empirical attention, researchers have hypothesised
that resilience is characterised by positive emotionality (Wolin
& Wolin, 1993; Block & Kremen, 1996; Masten, 2001) which
over time provide individuals with an enduring capacity to
‘bounce back’ when MDD would otherwise be expected
(Lazarus, 1993; Masten, 2001). Indeed, Fredrickson (2001) has
developed the ‘broaden-and-build’ hypothesis of positive emo-
tions which posits that whereas negative emotions narrow an indi-
vidual’s cognitive biases to increase the likelihood of depressive
symptoms, positive emotions broaden one’s thought–action
repertoires to navigate away from the disorder (Fredrickson,
2004). In the present study, PRS for MDD increased vulnerability
to both clinical and self-reported depression. This relationship is
mediated and increased by neuroticism as the negative emotions
it elicits are congruent with the disorder. Resilience may mediate
and ameliorate the relationship between PRS for depression and
MDD by promoting habituation to stressors, encouraging effica-
cious coping behaviours and prompting cognitive reappraisal
away from depressive mood states (Buhrmester et al. 2011;
Amstadter et al. 2016). These findings may have clinical applica-
tions insofar that therapeutic interventions for MDD may benefit
from focusing on positive emotions to facilitate recovery and
resilience rather than exclusively focused on alleviating psychiatric
symptoms (Fredrickson & Joiner, 2002).
Resilient individuals are believed to ‘bounce back’ from adver-
sity quickly and efficiently, akin to the way a spring stretches but
still returns to its original form (Lazarus, 1993). Current resilience
measures often fail to assess the concept across the lifespan or rec-
ognise that risk or adversity is an essential element of resilience
(Windle et al. 2011). Although the BRS assumes a trait-based con-
ceptualisation of resilience, the measure is framed in regard to
negative events (Smith et al. 2008), which frequently contribute
to the onset of the disorder. Moreover, the inclusion of PRS in
our analysis provides a measure of MDD risk that precede the
outcome. PRS provide a causal anchor for our mediation analyses
as they are a biological measure not subject to reverse causality.
Whilst the use of genetic factors is unusual in structural equation
modelling, they are helpful within this study as we can be more
certain of the causal path directions, and as such, this is not
Table 3. Fit statistics for the mediation models tested with both clinical and self-reported MDD status as an outcome
Model
MDD







1A SCID Neuroticism as a
mediator
142 165.97 0.977 0.972 0.038a 0.006 0.000 0.010
2A CIDI-SF 155 168.93 0.986 0.983 0.036a 0.005 0.000 0.009
1B SCID Resilience as a mediator 56 159.05 0.992 0.989 0.201 0.021 0.017 0.025
2B CIDI-SF 49 152.31 0.992 0.989 0.214 0.022 0.019 0.027
1C SCID Neuroticism & resilience
as separate mediators
281 336.70 0.996 0.996 0.107a 0.007 0.003 0.010
2C CIDI-SF 281 336.62 0.997 0.996 0.109a 0.007 0.003 0.010





289 637.17 0.978 0.975 0.107a 0.017 0.015 0.019
2D CIDI-SF 289 596.99 0.981 0.978 0.109a 0.016 0.014 0.018
SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, representing clinical MDD; CIDI-SF, Composite International Diagnostic Interview – Short Form, representing self-reported MDD;
MDD, Major Depressive Disorder; RMSEA, root-mean-square error of approximation; CFI, comparative fit index; TLI, Tucker–Lewis index.
aTLI and other incremental fit indices may not be that informative, because the RMSEA of the baseline model is lower than 0.158 (Kenny et al. 2015).
Fig. 2. Path diagram of Models 1C and 2C, which include a direct
bath between PRS and MDD status, an indirect path through
neuroticism and an indirect path through resilience. Model 1C
denotes SCID as the MDD outcome, representing clinical depres-
sion. Model 2C denotes CIDI-SF as the MDD outcome, represent-
ing self-reported depression. Values are standardised path
coefficients. All endogenous variables have been adjusted for
population stratification, sex and the age at which the variable
was measured. PRS, Polygenic Risk Score: MDD, Major
Depressive Disorder; SCID, Structured Clinical Interview for
DSM-IV Axis I Disorders; CIDI-SF, Composite International
Diagnostic Interview – Short Form.
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just a correlational analysis. However, a replication would be
beneficial. Furthermore, additional work should fully elucidate
the concept of resilience, as wide discrepancies exist in its defin-
ition and measurement (Bonanno et al. 2015). We argue that
future research needs to assess resilience across the lifespan to
fully understand the processes and mechanisms that underlie it,
and how it associates with depression.
Some limitations to this study warrant mention. Firstly, our
measures of MDD were taken at different time points. Although
our results were robust across the two measures of MDD, we
must note the difference in prevalence rates between the clinical
(16%) and self-reported (26%) measures. This may be due to a
sampling bias at re-contact in which participants with mental
health problems were more likely to take part in a study specific-
ally aimed to investigate mental health. Although it has been
argued that structured clinical interviews have better psychomet-
ric properties than self-report measures of MDD (Ekselius et al.
1994), research does suggest that the diagnostic classifications
obtained using measures such as the CIDI-SF accurately reflect
those made using the SCID (Kessler et al. 1998). Whilst clinical
and self-reported measures have been found to provide unique
information on MDD due to disproportionate weighting of symp-
toms within each measure (Uher et al. 2012), it is widely reported
that they each correlate highly when measuring the presence or
absence of MDD rather than the severity of symptoms (Fava
et al. 1986). For this reason, we believe that the use of a self-
reported and clinical measure of MDD is advantageous, despite
some limitations. In addition, the concept of resilience was
entirely self-reported; there is no consensus on how to measure
resilience, and other measures (e.g. the off-diagonal method
used by van Harmelen et al. 2017) may have produced different
results. It is also possible that MDD and neuroticism may influ-
ence the recall of experienced events, and that correlations
between these variables, and resilience, may be introduced as a
result. However, despite this potential limitation, neuroticism
has been demonstrated to be a relatively stable trait in many pre-
vious studies and the use of genetic PRS scores – which must
come causally prior to behaviours – provides an anchor for a
study that much previous research does not have available. A
final limitation of this study pertains to the differences in time
between the baseline and re-contact. There is disparity among
participants in regards to the time period between their baseline
testing and re-contact, with some participants having a longer
follow-up period than others. As a result, some participants
might have experienced more negative life events, thus increasing
their propensity for MDD.
In conclusion, this study suggests that polygenic risk for MDD
increases the risk for both clinical and self-reported depression
through independent effects on increasing neuroticism and redu-
cing resilience. This study suggests that two partially separate
mechanisms – neuroticism and resilience – influence vulnerability
and protection to MDD.
Supplementary material. To view supplementary material for this article,
please visit https://doi.org/10.1017/S0033291717003415
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